Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 16 Aug 2024 for ALX Oncology Holdings INC, €3,198. Read the official filing
Filing timeline
BuySaleSophia Randolph
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sophia Randolph: trading record in brief
Sophia Randolph, listed as senior executive, appears in our data through filings on ALX Oncology Holdings Inc shares, published by SEC (Form 4). We count 23 filings; the first trade dates from 10 May 2021 and the latest from 14 August 2024.
On the market, this insider has only sold: 12 sales, €1.1M in total. The rest of the record consists of 3 share grants and 8 option exercises. In 2024 alone, the filings show no purchases and 4 sales.
On 16 August 2024 came the latest disclosure, an open-market sale for €3,198 in ALX Oncology Holdings Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sophia Randolph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
1,365 shares@ US$2.580.1% of flowCommon StockSEC:0001415889-24-021480:0
3,273 shares@ US$5.81880.7% of flowCommon StockSEC:0001415889-24-019224:0
10,203 shares@ US$15.81696.0% of flowCommon StockSEC:0001415889-24-013237:0
30,000 shares0Common StockSEC:0001415889-24-004227:0
3,128 shares@ US$15.041.7% of flowCommon StockSEC:0001209191-24-000374:0
34,000 sharesCommon StockSEC:0001209191-23-043531:0
1,605 shares@ US$7.340.4% of flowCommon StockSEC:0001209191-23-041204:0
4,027 shares@ US$1.910.3% of flowCommon StockSEC:0001209191-23-036733:0
2,546 shares@ US$4.080.4% of flowCommon StockSEC:0001209191-23-036733:1
6,256 shares@ US$4.811.1% of flowCommon StockSEC:0001209191-23-036733:2
1,617 shares@ US$11.07040.7% of flowCommon StockSEC:0001209191-23-000483:0
8,404 shares@ US$1.910.6% of flowCommon StockSEC:0001209191-22-062178:0
12,731 shares@ US$4.082.0% of flowCommon StockSEC:0001209191-22-062178:1
25,339 shares@ US$4.814.6% of flowCommon StockSEC:0001209191-22-062178:2
37,000 shares0Common StockSEC:0001209191-22-045067:0
12,793 shares@ US$0.990.8% of flowCommon StockSEC:0001209191-21-070094:0
30,000 shares@ US$4.087.3% of flowCommon StockSEC:0001209191-21-066436:0
4,948 shares@ US$60.787417.6% of flowCommon StockSEC:0001209191-21-060229:0
900 shares@ US$76.4513.9% of flowCommon StockSEC:0001209191-21-055753:0
1,718 shares@ US$64.19716.4% of flowCommon StockSEC:0001209191-21-050823:0
7,087 shares@ US$54.856822.2% of flowCommon StockSEC:0001209191-21-046679:0
1,188 shares@ US$59.79653.9% of flowCommon StockSEC:0001209191-21-040221:0
1,925 shares@ US$61.11916.6% of flowCommon StockSEC:0001209191-21-031638:0
23 of 23 declarations
